CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 161 filers reported holding CYTOKINETICS INC in Q2 2020. The put-call ratio across all filers is 1.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,617,798 | -11.8% | 1,073,245 | -2.4% | 0.01% | -14.3% |
| Q2 2023 | $35,860,242 | +0.8% | 1,099,333 | +8.7% | 0.01% | 0.0% |
| Q1 2023 | $35,574,451 | -23.2% | 1,010,925 | +0.0% | 0.01% | -30.0% |
| Q4 2022 | $46,314,719 | -3.7% | 1,010,797 | +1.9% | 0.01% | -9.1% |
| Q3 2022 | $48,080,000 | +25.9% | 992,351 | +2.1% | 0.01% | +37.5% |
| Q2 2022 | $38,176,000 | +7.5% | 971,666 | +0.7% | 0.01% | +33.3% |
| Q1 2022 | $35,513,000 | -22.8% | 964,787 | -4.4% | 0.01% | -25.0% |
| Q4 2021 | $46,007,000 | +27.5% | 1,009,345 | -0.1% | 0.01% | +33.3% |
| Q3 2021 | $36,095,000 | +101.0% | 1,009,940 | +11.3% | 0.01% | +100.0% |
| Q2 2021 | $17,962,000 | -4.7% | 907,580 | +12.0% | 0.00% | -25.0% |
| Q1 2021 | $18,844,000 | +8.3% | 810,181 | -3.3% | 0.00% | +33.3% |
| Q4 2020 | $17,403,000 | -8.4% | 837,457 | -4.6% | 0.00% | -25.0% |
| Q3 2020 | $19,006,000 | +1.4% | 877,936 | +10.4% | 0.00% | 0.0% |
| Q2 2020 | $18,747,000 | +105.6% | 795,365 | +2.9% | 0.00% | +33.3% |
| Q1 2020 | $9,118,000 | +12.3% | 773,308 | +1.0% | 0.00% | +50.0% |
| Q4 2019 | $8,121,000 | -9.7% | 765,408 | -3.2% | 0.00% | 0.0% |
| Q3 2019 | $8,997,000 | +18.1% | 790,618 | +16.8% | 0.00% | 0.0% |
| Q2 2019 | $7,616,000 | +73.1% | 676,985 | +24.5% | 0.00% | +100.0% |
| Q1 2019 | $4,400,000 | +30.8% | 543,796 | +2.2% | 0.00% | 0.0% |
| Q4 2018 | $3,364,000 | -37.4% | 532,327 | -2.4% | 0.00% | 0.0% |
| Q3 2018 | $5,370,000 | +29.8% | 545,314 | +9.4% | 0.00% | 0.0% |
| Q2 2018 | $4,138,000 | +34.6% | 498,546 | +16.7% | 0.00% | 0.0% |
| Q1 2018 | $3,075,000 | -11.5% | 427,128 | +0.2% | 0.00% | 0.0% |
| Q4 2017 | $3,476,000 | -49.2% | 426,453 | -9.6% | 0.00% | -50.0% |
| Q3 2017 | $6,843,000 | +21.0% | 471,858 | +1.0% | 0.00% | 0.0% |
| Q2 2017 | $5,655,000 | +15.7% | 467,312 | +22.8% | 0.00% | +100.0% |
| Q1 2017 | $4,889,000 | +7.4% | 380,427 | +1.5% | 0.00% | 0.0% |
| Q4 2016 | $4,554,000 | +39.1% | 374,782 | +5.1% | 0.00% | 0.0% |
| Q3 2016 | $3,273,000 | +13.4% | 356,547 | +17.3% | 0.00% | 0.0% |
| Q2 2016 | $2,885,000 | -1.9% | 303,986 | -27.1% | 0.00% | 0.0% |
| Q1 2016 | $2,942,000 | -24.7% | 417,189 | +11.7% | 0.00% | 0.0% |
| Q4 2015 | $3,906,000 | +66.8% | 373,343 | +6.6% | 0.00% | 0.0% |
| Q3 2015 | $2,342,000 | +4.6% | 350,152 | +5.2% | 0.00% | 0.0% |
| Q2 2015 | $2,238,000 | -0.2% | 332,977 | +0.6% | 0.00% | 0.0% |
| Q1 2015 | $2,243,000 | -15.1% | 330,875 | +0.4% | 0.00% | 0.0% |
| Q4 2014 | $2,641,000 | +115.8% | 329,711 | -5.1% | 0.00% | – |
| Q3 2014 | $1,224,000 | -25.8% | 347,548 | +0.7% | 0.00% | -100.0% |
| Q2 2014 | $1,649,000 | -50.0% | 345,035 | -0.6% | 0.00% | 0.0% |
| Q1 2014 | $3,297,000 | +44.2% | 347,039 | -1.3% | 0.00% | 0.0% |
| Q4 2013 | $2,286,000 | -10.7% | 351,731 | +4.0% | 0.00% | 0.0% |
| Q3 2013 | $2,560,000 | – | 338,162 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,989,218 | $47,348,000 | 10.09% |
| EcoR1 Capital, LLC | 2,139,697 | $20,306,000 | 8.01% |
| Healthcare Value Capital, LLC | 100,000 | $949,000 | 1.15% |
| DAFNA Capital Management LLC | 150,000 | $1,424,000 | 1.13% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 151,106 | $1,434,000 | 1.07% |
| Avoro Capital Advisors LLC | 503,900 | $4,782,000 | 1.06% |
| ACUTA CAPITAL PARTNERS, LLC | 140,969 | $1,338,000 | 0.64% |
| Iguana Healthcare Management, LLC | 150,000 | $1,424,000 | 0.58% |
| WASATCH ADVISORS LP | 1,746,096 | $16,570,000 | 0.25% |
| Virtus ETF Advisers LLC | 29,379 | $279,000 | 0.21% |